In Phase A, individuals will obtain unique doses and schedules of oral ABBV-744 tablet to discover Safe and sound dosing regimen. Further individuals might be enrolled with the discovered monotherapy dosign program. In Section B, individuals will receive oral ruxolitinib and ABBV-744 is going to be given as "increase-on" therapy. https://dallasjxjuf.therainblog.com/31051463/abbv-744-clinical-trial-phase-2-data-things-to-know-before-you-buy